Investing in the Future of Pediatric Health
A mission-driven venture capital firm advancing breakthrough therapies for children
PediaMed Ventures is a purpose-built venture capital firm dedicated to solving one of medicine’s most overlooked challenges: the pediatric innovation gap. We invest in early-and mid-stage companies developing transformative therapies for children—and we selectively acquire and scale later-stage assets that have been deprioritized by traditional markets.
Who We Are
PediaMed Ventures was founded to close the persistent gap between life-saving drug innovation and the needs of pediatric patients. With deep expertise in biotech, commercialization, and impact finance, we invest in scalable solutions across the therapeutic development lifecycle—from discovery to delivery.
How We Invest
We target:
- Early-stage biotech and therapeutic platforms focused on pediatric populations
- Pediatric indications for adult-approved drugs
- Non-core or underutilized assets in need of strategic repositioning
We work alongside scientists, nonprofits, and industry partners to accelerate access and equity in children’s health.
How We’re Different
We combine the energy of venture capital with the flexibility of growth investing:
- Venture-First Approach: We lead and syndicate early-stage rounds for pediatric biotech innovators.
- Selective Acquisitions: We identify non-strategic or shelved products with strong pediatric potential and bring them back to life.
- Mission-Locked Strategy: Our success is measured in lives improved, not just multiples returned.
Our Values
- Pediatric-First: Children are our priority, not an afterthought.
- Evidence-Driven: We invest with scientific rigor and clinical insight.
- Impact-Aligned: Every dollar aims to create both health and financial returns.
Shared leadership. Independent governance. Unified vision.
Let’s build the future of pediatric medicine—together.
If you’re a founder, scientist, co-investor, or institutional LP aligned with our mission, we’d love to hear from you.